← Back
Data updated: Mar 10, 2026
PLIVA LACHEMA
Oncology
PLIVA LACHEMA is a generic drug manufacturer focused on Oncology. Key products include PACLITAXEL.
2008
Since
4
Drugs
-
Trials
31
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
CARBOPLATIN 2026-02-04
OXALIPLATIN 2026-01-15
OXALIPLATIN 2025-10-22
Labeling
IRINOTECAN HYDROCHLORIDE 2025-08-20
Labeling
IRINOTECAN HYDROCHLORIDE 2025-08-20
Labeling
IRINOTECAN HYDROCHLORIDE 2025-08-20
Labeling
IRINOTECAN HYDROCHLORIDE 2025-08-20
Labeling
IRINOTECAN HYDROCHLORIDE 2025-08-20
Labeling
PACLITAXEL 2025-08-19
PACLITAXEL 2025-07-10
Labeling
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Oncology 100%
1 drugs
Pipeline Strength Pro
Loading...
Active (1)
Discontinued (3)
Company Info
- First Approval
- 2008-03-12
- Latest
- 2008-12-02
- Applications
- 4